Described herein are compositions and methods for the treatment and diagnosis of mesothelioma, and determination of prognosis of mesothelioma patients after surgical operation. Specifically, the invention relates to microRNA molecules associated with treatment, diagnosis and determination of prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
